Predicted annual costs for inpatients with diabetes and foot ulcers in a developing country-a simulation of the current situation in Brazil

Diabet. Med. Aims  The objective of this cost‐of‐illness analysis was to quantify the annual costs associated with hospital admission for people with diabetes and foot ulcers in Brazil. Methods  A hypothetical cohort was simulated using a decision tree model. Prevalence and incidence rates and clini...

Full description

Saved in:
Bibliographic Details
Published in:Diabetic medicine 2010-01, Vol.27 (1), p.109-112
Main Authors: Rezende, K. F., Ferraz, M. B., Malerbi, D. A., Melo, N. H., Nunes, M. P., Pedrosa, H. C., Chacra, A. R.
Format: Article
Language:English
Subjects:
amputation
Amputation - economics
Biological and medical sciences
Brazil - epidemiology
Cost-Benefit Analysis
developing countries
Diabetes Mellitus, Type 2 - economics
Diabetes Mellitus, Type 2 - epidemiology
Diabetes Mellitus, Type 2 - surgery
Diabetes. Impaired glucose tolerance
diabetic foot
Diabetic Foot - economics
Diabetic Foot - surgery
economics
Endocrine pancreas. Apud cells (diseases)
Endocrinopathies
Etiopathogenesis. Screening. Investigations. Target tissue resistance
Feeding. Feeding behavior
Female
Fundamental and applied biological sciences. Psychology
Humans
Male
Medical sciences
Prevalence
Vertebrates: anatomy and physiology, studies on body, several organs or systems
Vertebrates: endocrinology
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Diabet. Med. Aims  The objective of this cost‐of‐illness analysis was to quantify the annual costs associated with hospital admission for people with diabetes and foot ulcers in Brazil. Methods  A hypothetical cohort was simulated using a decision tree model. Prevalence and incidence rates and clinical outcomes were estimated from published studies and applied to the general Brazilian population over 30 years. Costs were quoted in Brazilian real (BRL) and converted to US dollars ($US) at the 2008 currency exchange rate ($US1 = BRL 1.64). In the sensitivity analysis, we reduced and increased rates to assess the robustness of the cost estimates. Results  In this hypothetical cohort there are 6.48 million (95% confidence interval 4.47–7.12) Brazilians citizens with Type 2 diabetes. Each year, approximately 323 000 (89 500–484 500) of these people develop foot ulcers and almost 97 200 (17 900–169 600) require hospital admission as a result. Each year, almost 46 300 (8500–80 900) limb amputations and 12 400 (2300–21 700) deaths occur as a result of diabetic foot disease in Brazil. The annual cost associated with these hospital admissions is estimated to be almost $US264m ($US51m–461m). The estimated cost for patients with amputation is nearly $US128m ($US24.5m–222.3m). Conclusions  Our model shows that the social and economic impact of diabetic foot disease in Brazil is high. Government decision makers should reflect on the current situation and provide organized foot care throughout the whole country.
ISSN:0742-3071
1464-5491
DOI:10.1111/j.1464-5491.2009.02871.x